 |
|
|
 |
|
|
|
|
|
|
|
|
|
|
| |
Poster number: 158
No. visits: 88
Title: DONOR LYMPHOCYTE INFUSIONS FOR CHRONIC MYELOID LEUKAEMIA RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANT: PROGNOSTIC FACTORS FOR A PURE GVL EFFECT ARE DIFFERENT ACCORDING TO THE STAGE OF RELAPSE
Authors : Cesare Guglielmi,
Iacobelli S. Apperley J. Bunjes D. Jacobs P. Kolb H.-J. Ljungman P. Olavarria E. Schattenberg A. Van Biezen A.
Centre: Universitŕ di Roma La Sapienza
- Click HERE to contact the author -
|
| | |
Poster number: 322
No. visits: 91
Title: BOSUTINIB (SKI-606) COOPERATES WITH DASATINIB IN COUNTERACTING GROWTH AND VIABILITY OF CML CELLS CARRYING THE T315I MUTANT OF BCR/ABL
Authors : Karoline Gleixner,
Remsing Rix L.L. Rix U. Meyer R.A. Herrmann H. Schuch K. Pickl W.F. Sillaber C. Augustin M. Till J.H.
Centre: Medical University of Vienna
- Click HERE to contact the author -
|
| |
| | | | |
|
| | | | |
| |
Poster number: 634
No. visits: 91
Title: RELEASE OF INTRACELLULAR CALCIUM PRIMES CHRONIC MYELOID LEUKAEMIA CELLS FOR TYROSINE KINASE INHIBITOR (TKI)-INDUCED APOPTOSIS
Authors : Sylvia Forchap,
Pirmohamed M. Clark R.E.
Centre: Heamatology, University of Liverpool
- Click HERE to contact the author -
|
| | |
Poster number: 635
No. visits: 98
Title: A SHORT (12M) IFNA/IMATINIB COMBINED THERAPY CAN SECURE LONG TERM MAINTENANCE OF IMATINIB INDUCED CYTOGENETIC REMISSION AFTER DISCONTINUATION OF IMATINIB IN CML PATIENTS WITHOUT MOLECULAR REMISSION
Authors : Izhar Hardan,
Stemmer S.M. Amariglio N. Koren-Michowitz M. Levi I. Shimoni A. Binenbaum Y. Ben-Yehuda D. Bennett M. Rechavi G.
Centre: sheba Medical Center
- Click HERE to contact the author -
|
| |
| | | | |
|
| | | | |
| |
Poster number: 637
No. visits: 90
Title: A STUDY OF PLASMA LEVELS OF IMATINIB AND ITS BIOACTIVE METABOLITE CGP-74588 REVEALS NO CORRELATION WITH SUBSEQUENT CLINICAL OUTCOME IN IMATINIB-TREATED CHRONIC MYELOID LEUKAEMIA
Authors : Andrea Davies,
Hayes A.K. Giannoudis A. Lucas C.M. Knight K. Watmough S.J. Pirmohamed M. Clark R.E.
Centre: University of Liverpool
- Click HERE to contact the author -
|
| | |
Poster number: 643
No. visits: 97
Title: LONG-TERM SURVIVAL OF PATIENTS WITH LATE CHRONIC PHASE PH-POSITIVE CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITOR THERAPY AFTER INTERFERON FAILURE
Authors : Anna Turkina,
Stakhina O.V. Gusarova G.A. Zakharova E.S. Chelysheva E.Yu. Vinogradova O.Yu. Kolosheinova T.I. Goryacheva C.R. Kolosova L.Yu. Domracheva E.V.Zakharova AV, Abakumov EM, Kulikov SM, Khoroshko ND.
Centre: Hematological Research Center, RAMS, Moscow
- Click HERE to contact the author -
|
| |
| | | | |
|
| | | | |
| |
Poster number: 644
No. visits: 84
Title: PREGNANCY AMONG THE PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB THERAPY
Authors : Ekaterina Chelysheva,
Turkina A.G. Gusarova G.A. Kolosheinova T.I. Sokolova M.A. Khoroshko N.D. Pepelyaeva V.M. Gavrilova L.V.
Centre: Hematology Research Center of Russian Academy of Medical Sciences
- Click HERE to contact the author -
|
| | |
Poster number: 856
No. visits: 84
Title: COMPARISON OF HIGH PREFORMANCE LIQUID CHROMATOGRAPHY-ULTRAVIOLET DETECTION (HPLC-UV) VS LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY (LC/MS/MS) TO DETERMINE IMATINIB PLASMA LEVELS IN CML-CP PATIENTS
Authors : Abdalla Awidi,
Salem I.I. Najib N. Mefleh R. Tarawneh B.
Centre: Jordan University and International Pharmaceutical Research Center, Amman (JORDAN)
- Click HERE to contact the author -
|
| |
| | | | |
|
| | | | |
| |
Poster number: 859
No. visits: 83
Title: CHRONIC MYELOID LEUKAEMIA PATIENTS WITH THE E13A2 BCR-ABL TRANSCRIPT HAVE INFERIOR RESPONSE TO IMATINIB THAN E14A2 PATIENTS
Authors : Claire Lucas,
Harris R.J. Wang L. Knight K. Watmough S.J. Clark R.E.
Centre: Royal Liverpool Unviversity Hospital
- Click HERE to contact the author -
|
| | |
Poster number: 860
No. visits: 98
Title: OVERVIEW OF CHRONIC MYELOID LEUKEMIA AND CURRENT DIAGNOSIS AND TREATMENT PATTERNS FROM 15 HOSPITALS IN CHINA
Authors : Jianxiang Wang,
Wang Y. Qiu L.G. Huang X.J. Jiang B. Wu D.P. Sun A.N. Hu J.D. Liu T.B. Liu T.
Centre: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
- Click HERE to contact the author -
|
| |
| | | | |
|
| | | | |
| |
Poster number: 861
No. visits: 97
Title: CHRONIC MYELOID LEUKEMIA AS SECOND MALIGNANCY; A RETROSPECTIVE MULTICENTRIC STUDY
Authors : Emilio Iannitto,
Minardi V. Barone R. Cascavilla N. Caracciolo C. Di Raimondo F. Ferrara F. Franco G. Liardo E. Mancuso S.
Centre: Division of Haematology, University of PAlermo
- Click HERE to contact the author -
|
| | |
Poster number: 866
No. visits: 94
Title: PROANGIOGENIC CYTOKINES IN CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB MESYLATE
Authors : Kostyantyn Kotlyarchuk,
Lukavetsky L. Danysh O. Lukjanova A. Kolisnyk M. Maslyak Z.
Centre: SI Institute of Blood Pathology and Transfusion Medicine, AMS of Ukraine
- Click HERE to contact the author -
|
| |
| | | | |
|
| | | | |
| |
Poster number: 867
No. visits: 86
Title: IMATINIB DOSE ESCALATION FOR CML RESISTANT PATIENTS IS USEFUL IN GENERAL PRACTICE: IMPACT ON CYTOGENETIC REMISSION
Authors : Andrey Zaritskey,
Centre: SPBGMU by academic I.P. Pavlov
- Click HERE to contact the author -
|
| | | | | |
|
|
|
|
|
